American Journal of Infection Control

To prepare NYS hospitals for reporting in The National Healthcare Safety Network's Antimicrobial Use and Resistance (AUR) Module, the Healthcare Association of New York State (HANYS) launched a voluntary Antibiotic Stewardship Collaborative (ASC) in

Contact tracing is a critical strategy to control COVID-19 transmission.1 However, barriers such as program costs hinder efforts to expand contact tracing in US health departments.2 One potential solution is augmenting health departments by

The International Nosocomial Infection Control Consortium (INICC) was founded in 2002 as a global research network for healthcare-associated infections (HAI).1 Its main goal is to encourage evidence-based infection prevention recommendations in order

The aim of this study was to compare the 2 mouthwash solutions, including chlorhexidine (CHG) and ozonated water (OZW) to reduce the risk of ventilator-associated pneumonia (VAP) in patients on mechanical ventilation in intensive care unit (ICU).

Health care workers (HCW) comprise a group that is particularly affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and exposed to high viral loads, higher than the general population.1-3 Transmissibility between asymptomatic or

SARS-CoV-2; Nosocomial infectionThe omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has swept the world, and a large-scale outbreak occurred in Shanghai in early March 2022. To cope with the need to treat COVID-19, a

Periprosthetic joint infections (PJIs) of hip and knee replacements are a subset of surgical site infections (SSIs) that cannot be treated with antibiotics or local wound care and require repeat surgeries and prolonged intravenous antibiotics. PJIs

To evaluate potential viral contamination on the surfaces of personal protective equipment (PPE) in COVID-19 wards.

Clostridioides difficile infection (CDI) is the most common health-care associated infection and is associated with significant costs, morbidity, and mortality.1,2 The average cost per case of nosocomial CDI is $34,000, with annual cost estimated at

Sphingomonas paucimobilis is an aerobic, non-fermentative, Gram-negative opportunistic bacillus. Being an oligotrophic bacterium, S paucimobilis can survive in low-nutrient environments.1 Despite claims of low-pathogenicity,1,2 there have been